G433-1009 Screening compound: N-(1,3-dimethyl-2-oxo-6-phenoxy-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-3,4-difluorobenzene-1-sulfonamide

G433-1009 Screening compound: N-(1,3-dimethyl-2-oxo-6-phenoxy-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-3,4-difluorobenzene-1-sulfonamide
G433-1009 Screening compound: N-(1,3-dimethyl-2-oxo-6-phenoxy-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-3,4-difluorobenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G433-1009
N-(1,3-dimethyl-2-oxo-6-phenoxy-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-3,4-difluorobenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G433-1009

Molecular Formula

C21H17F2N3O4S (C21 H17 F2 N3 O4 S)

Compound Name

N-(1,3-dimethyl-2-oxo-6-phenoxy-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-3,4-difluorobenzene-1-sulfonamide

IUPAC name

N-(13-dimethyl-2-oxo-6-phenoxy-23-dihydro-1H-13-benzodiazol-5-yl)-34-difluorobenzene-1-sulfonamide

SMILES

CN(c(c(N1C)c2)cc(NS(c(cc3)cc(F)c3F)(=O)=O)c2Oc2ccccc2)C1=O

InChI

InChI=1S/C21H17F2N3O4S/c1-25-18-11-17(24-31(28,29)14-8-9-15(22)16(23)10-14)20(12-19(18)26(2)21(25)27)30-13-6-4-3-5-7-13/h3-12,24H,1-2H3

InChI Key

FPTRZKIYCLJJCI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27141611

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.45

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.394

Distribution Coefficient, logD

4.100

Water Solubility, LogSw

-4.37

Polar Surface Area

64.709

Acid Dissociation Constant (pKa)

7.41

Base Dissociation Constant (pKb)

-2.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.50

G433-1009 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G433-1009 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G433-1009?
Check Price and Availability of G433-1009, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G433-1009 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G433-1009
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G433-1009
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G433-1009 available by request